Adaptimmune Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $189k | 194k | 0.97 |
| 2024-03-31 | $458k | 290k | 1.58 |
| 2023-09-30 | $988k | 1.3M | 0.78 |
| 2023-06-30 | $1.1M | 1.2M | 0.93 |
| 2023-03-31 | $964k | 884k | 1.09 |
| 2022-12-31 | $1.4M | 973k | 1.46 |
| 2022-06-30 | $2.3M | 1.4M | 1.70 |
| 2021-06-30 | $4.2M | 981k | 4.26 |
| 2021-03-31 | $7.9M | 1.5M | 5.31 |
| 2020-12-31 | $7.8M | 1.5M | 5.39 |
| 2019-09-30 | $1.3M | 830k | 1.51 |
| 2019-06-30 | $3.3M | 820k | 4.02 |
| 2019-03-31 | $3.5M | 824k | 4.30 |
| 2018-12-31 | $4.9M | 856k | 5.75 |
| 2018-09-30 | $11M | 775k | 13.56 |
| 2018-06-30 | $9.1M | 763k | 11.87 |
| 2018-03-31 | $9.1M | 807k | 11.23 |
| 2017-09-30 | $15k | 1.8k | 8.33 |
| 2015-12-31 | $7.0k | 600 | 11.67 |
| 2015-09-30 | $2.0k | 170 | 11.76 |
| 2015-06-30 | $3.0k | 170 | 17.65 |